Document zbGe2Yg6D49ND7GeqaR2QVgNm

,%A 44-A BAKEUTE COMPANY VIlDf -JF UNION CAftfetOff CORPORATION COPY u Dr* V* B* Aolcart - aa hr* B l Bor^-o Clifton #r* V. B* Corbet - fhila. ^r* 3* V# Mottjghlia 292 Kid Dr* t* V, Nal* - 60 r.* ll-- Kr. 0* f, forlorn - Room 1901 Karcb #5, 1?S5 Tralliirap Coapapy lfslt7 nnla Street : allaielpftla Ji'v, a* Attan-:oo: Mr* Arthur ^r ?ir. ^aado*: Mr. Corun bti ponied on to t>.l office j-uar station pertain* lag to U.e -se of -.r vinyl pl-n.^icd ri^ld iu.*#,'t l oratlatlon dost-jsXt d V A-3313 'lrar 31 as a fom^d pacta,:t to contain asdlainal pills and/or eapaol:* for oit.it r tutaao or aalselo* It is v. optedon of oar Industrie! Medicine and Toxicology Department tm- v.ls foroulatiin toili bo oufo for ase lb packaging of mtdioetions in Cry rom sact i* dry tarl-jtt o.- e*:-ilr* *e met ra pt.aster tint Wda opinion to based poa tfcia portlcaUr application and xierod >>n rut-peat koo-ls'-e, t:.* co-apaanci in <{ueolian voald not b* coat! d* rod eeceptebie Ry our doctor* for food packaging use or for liquid or paet* fora abdications. Tn writer regrets t;. Iraj-tt ot time it bao taken to get tt.it Information to yi. *e kope yo* will find It htlpf^X* Vo recognise V>at yi up ala-1 wont to ootala Ui* opinion of tne rood and Afelalatra* t-on e*.* rt* la -a.abint.toa* w oald be Osp,y to mi you do ai^and l* fact, as a matter of policy * urge oar eu*tosM*ro to do oo* ?l*4*t trod -s a eo. jr of aay 1-tter yea writ*' to to* K.1*A oo loat vt ean folio* t.roigh Oita a latter to tbem giving tbc* tae logredUo,* of oar ebe*t* Soars nr? truly, Aasi stoat Males hooafW r JT.riK BTFI^IOS ucc 063640 RECEIVED MAR 2 5 1958 RTTf/.U Utt.CIM | WaI Di?z\ riWVHR A 44.A AKEUTC COMPANY (VISION OF UNION CARBIDE Qt Mr* Q, T* Soriba torn 1901 Dr. T. V. Bala - 60 E. L2 Karoh I6f 1#8 Sheeting* Tranallvrap Company TSA-3310 Clear 31 I u attaching a copy of a letter I bare written to Transllvrap Company pertaining to the uae of V3A-3310 Clear 31 for packaging medicinal pills and/or capsules. Thla letter vaa baaed on information supplied by Dr. Bale to m In bis letter of March 10. I will not nail this letter until I have received jour eoaaents on the wording. Tour prompt consideration of thla will be appreciated. LDd> RVS Attach. Original signed by L D.. Burnett^ Jc. L. D. 0umett# Jr. UCC 063641 RECEIVED MAf; 2 0 1358 voxiwo.tt) iKiz'.mm Hr. L. D. Burnett, Jr. Bakellte Company 292 HadIson Avenue Hew York Dr. V. B. Acksrt Hr. H* L. Burpo Mr. V. B. Corbet Hr. J. V. McLaughlin Dr. H. 7. Smyth. Jr. Hr. 0. f. Scribe March 10. 1959 V8A-3310 Clear 31 Packaging Dear Mr. Burnettt It is proposed that this foraulatlon Is to be need as .010* thick clear rigid sheets as a foraed package to contain aedlelnal pills and/or capsules In a wide variety of aedlelnal agents weed for either buaaas or aalnals. This foraulatlon would not be acceptable for food paekaglng use or for liquid or paste fora aedloatloas. It would seea safe, however, for use In paekaglng of Medications In dry fora suoh as dry tablets or capsules. The weight of VSA-3310 Clear 31 In sueh a package would be of alnor quantity and the only Ingredient of laaedlate concern would be the 20 stabiliser. This stsblllser would not he extracted unless swlsture or oils were present. Ve auet eaphaelse that thle opinion la based upon this particular application and usage. For jour Inforaatlon. I na enclosing a saspls of a drug eapsuls which X think Is so packaged. Tory truly youra. V fhoaas V. Hale. M. D. enclosure MEDICAL DXKBCTQM ucc 063642 FOR INTERNAL CORRESPONDENCE ONLY <i> BAKELITE COMPANY A DIVISION OF UNION CARBIDE AND CARBON CORPORATION BAKELITE To (tia) Company location Or. T. W. Nale 60 E. U2 Street Room 920 UH3 NEW YORK 17, N.Y. March It, 1958 Originating Dag#. Sheetings Aoproring fatior Mi Copy * Dr. W. B. Ackart - BB Mr. H. L. Burpo - Clifton Mr. W. B. Corbet - Rilla. Mr. J. W. McLaughlin - 292 Mad. V5A.-3310 Clear 31 Packaging VINYLITE GENERAL OmCES >0 EAST42R STREET NEW YORK We have received a request to comment on the suitability of our .010" thick clear planished rigid sheets as a formed package to contain medi cinal pills. This particular package, as described to the writer, would be a formed unit package to hold pills (for animals) and antibiotics (for humans), the latter being in capsule form. The formulation for our V5A-331Q Clear 31 is as follows: VTNW-1 VYHH-3 D-15 Salol Steric acid 1% 811 Dispersion 87.35 2 10.00 % 2.00 % .1*0 2 .1752 .0752 100.0002 It is recognized that limited information is supplied here regarding the products to be packaged. Possibly more can be developed, but this appli cation was developed through one of our resellers who is desirous of ob taining the rigid sheet business and we have not had direct contact with the ultimate user of the package, which is Wyeth Drug Company. If it is possible for you to comment on this application regarding the suitability of the above formulation for this end use, it would be appreciated. LD3:3VS ucc 063643 RECEIVED MAft 6 1358 wmsim mmm t feDCQlMl MIIM